In the US, all vaccines must be approved or licensed by the Food and Drug Administration (FDA), after which every vaccine is evaluated by an independent group of experts who review the trial data and recommend how the vaccine should be used.
This site reflects US immunization policies, including links to Centers for Disease Control and Prevention (CDC) immunization schedules.
CDC Recommendations
CDC RECOMMENDATIONS
Parent-friendly immunization schedule for infants and children from birth through age 6 years
CDC RECOMMENDATIONS
Spanish version of parent-friendly immunization schedule for infants and children from birth through age 6 years
CDC RECOMMENDATIONS
CDC recommended immunization schedules from birth through age 18 years
CDC RECOMMENDATIONS
CDC recommended immunization schedules for adolescents age 7-18 years
CDC RECOMMENDATIONS
Spanish version of CDC recommended immunization schedules for adolescents age 7-18 years
CDC RECOMMENDATIONS
CDC recommended immunization schedules for adults age 19 years and older
Vaccine Safety
Advisory Committee on Immunization Practices
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) is an independent group of experts who review safety and efficacy data to make recommendations for the use of vaccines in the US, including schedules regarding the appropriate timing, dosage, and contraindications.
ACIP includes ex-officio members from other federal agencies and non-voting representatives of liaison organizations that bring related immunization expertise.
ACIP develops recommendations for the routine administration of vaccines, along with schedules regarding the appropriate timing, dosage, and contraindications.
Recommended Vaccines by Age Infographics
Recommended Vaccines By Age (Spanish)
Infographics in Spanish of vaccines recommended for children, adolescents, adults, and adults 65+, and the risks of vaccine-preventable diseases
Recommended Vaccines By Age (English)
Infographics of vaccines recommended for children, adolescents, adults, and adults 65+, and the risks of vaccine-preventable diseases
Latest Posts
Harnessing the Power of Local Data
NFID dashboard aims to empower stakeholders with hyperlocal data to increase US adult respiratory vaccine uptake
Closing the Gap in RSV Prevention
NFID Medical Director Robert H. Hopkins, Jr., MD, shares his perspective on the importance of respiratory syncytial virus (RSV) prevention
New Collaboration Aims to Empower Black Communities to Help Protect against Preventable Respiratory Diseases
NFID partners with National Council of Negro Women Good Health WINs to raise awareness about COVID-19, flu, pneumococcal disease, and RSV
Updated February 2023
Source: Centers for Disease Control and Prevention